- Home
- STIM vs TTRX Comparison
STIM vs TTRX Comparison
Compare STIM & TTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STIM
- TTRX
- Stock Information
- Founded
- STIM 2003
- TTRX 2015
- Country
- STIM United States
- TTRX United States
- Employees
- STIM N/A
- TTRX N/A
- Industry
- STIM Medical/Dental Instruments
- TTRX Biotechnology: Pharmaceutical Preparations
- Sector
- STIM Health Care
- TTRX Health Care
- Exchange
- STIM Nasdaq
- TTRX Nasdaq
- Market Cap
- STIM 224.8M
- TTRX 257.8M
- IPO Year
- STIM 2018
- TTRX N/A
- Fundamental
- Price
- STIM $1.97
- TTRX $4.00
- Analyst Decision
- STIM Strong Buy
- TTRX
- Analyst Count
- STIM 2
- TTRX 0
- Target Price
- STIM $7.00
- TTRX N/A
- AVG Volume (30 Days)
- STIM 1.6M
- TTRX 110.2K
- Earning Date
- STIM 11-04-2025
- TTRX 01-01-0001
- Dividend Yield
- STIM N/A
- TTRX N/A
- EPS Growth
- STIM N/A
- TTRX N/A
- EPS
- STIM N/A
- TTRX N/A
- Revenue
- STIM $129,873,000.00
- TTRX N/A
- Revenue This Year
- STIM $105.70
- TTRX N/A
- Revenue Next Year
- STIM $11.77
- TTRX N/A
- P/E Ratio
- STIM N/A
- TTRX N/A
- Revenue Growth
- STIM 78.61
- TTRX N/A
- 52 Week Low
- STIM $0.60
- TTRX $3.65
- 52 Week High
- STIM $5.92
- TTRX $26.50
- Technical
- Relative Strength Index (RSI)
- STIM 28.30
- TTRX N/A
- Support Level
- STIM $2.01
- TTRX N/A
- Resistance Level
- STIM $3.09
- TTRX N/A
- Average True Range (ATR)
- STIM 0.25
- TTRX 0.00
- MACD
- STIM -0.08
- TTRX 0.00
- Stochastic Oscillator
- STIM 6.88
- TTRX 0.00
About STIM Neuronetics Inc.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.